Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (693)	2/15/1998 3:27:00 PM
From: Jim Roof	Read Replies (1) \| Respond to of 1432

That does not answer my question. You say that Biotime is fraudulent in the way that they are promoting their product and I do not want to hear another thing from you until you can answer that question and that question only. As for their cash position - where do you get your information? Jim

To: Bill Wexler who wrote (693)	2/15/1998 6:39:00 PM
From: Keith J	Read Replies (2) \| Respond to of 1432

The company had over $6 million in cash and cash equivalents (as per the 10-Q) as of Dec. 31, 1997. The company had spent less than $15 million since its inception in 1990 as of Dec. 31st, and about $1.2 million in the Dec. quarter. Unless you believe they are filing false information to the SEC. You speak of dilution. There was a rights offering about a year ago, but that was not that large and was offered to current stockholders at that time. But nothing else that I know of. Unless you can put some concrete information on the table, please do not bother us. KJ